Related Experiment Video
Updated: Mar 10, 2026

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone
Bin Huang1, Wenhao Wang1, Qingchu Li1
1Academy of Orthopedics, Guangdong Province, Department of Orthopedics, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.
Insights
Osteoblasts secrete Cxcl9, an angiostatic factor that inhibits blood vessel formation and bone growth by blocking vascular endothelial growth factor. Targeting Cxcl9 may treat bone loss diseases.
Area of Science:
- Bone biology
- Angiogenesis
- Cellular communication
Background:
- Osteoblast-endothelial cell (EC) communication is crucial for bone remodeling.
- Molecular mechanisms regulating this crosstalk are not fully understood.
Purpose of the Study:
- To identify molecular factors involved in osteoblast-EC communication.
- To elucidate the role of these factors in bone angiogenesis and osteogenesis.
Main Methods:
- Identification of Cxcl9 as an osteoblast-secreted factor.
- In vitro and in vivo experiments using mouse bone models.
- Analysis of vascular endothelial growth factor (VEGF) interactions.
- Investigation of mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway.
Main Results:
- Cxcl9, secreted by osteoblasts, acts as an angiostatic factor.
- Cxcl9 inhibits angiogenesis and osteogenesis by interfering with VEGF binding to ECs and osteoblasts.
- mTORC1 signaling upregulates Cxcl9 expression via STAT1, enhancing STAT1 binding to the Cxcl9 promoter.
Conclusions:
- Osteoblast-derived Cxcl9 plays a critical role in regulating bone angiogenesis and osteogenesis.
- Targeting Cxcl9 presents a potential therapeutic strategy to enhance bone angiogenesis and combat bone loss.
Abstract:
Communication between osteoblasts and endothelial cells (ECs) is essential for bone turnover, but the molecular mechanisms of such communication are not well defined. Here we identify Cxcl9 as an angiostatic factor secreted by osteoblasts in the bone marrow microenvironment. We show that Cxcl9 produced by osteoblasts interacts with vascular endothelial growth factor and prevents its binding to ECs and osteoblasts, thus abrogating angiogenesis and osteogenesis both in mouse bone and in vitro. The mechanistic target of rapamycin complex 1 activates Cxcl9 expression by transcriptional upregulation of STAT1 and increases binding of STAT1 to the Cxcl9 promoter in osteoblasts. These findings reveal the essential role of osteoblast-produced Cxcl9 in angiogenesis and osteogenesis in bone, and Cxcl9 can be targeted to elevate bone angiogenesis and prevent bone loss-related diseases.
Related Concept Videos
Osteoclasts in Bone Remodeling
Regulation of Angiogenesis and Blood Supply
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Regulation of Hematopoietic Stem Cells

